Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease

Inflammatory Bowel Diseases

Volumn 14, Issue 3, 2008, Pages 310-317

  Sakiyama, Toshio ^a   Fujita, Hiroshi ^a   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Autoantibody; Crohn's disease; Enteroendocrine cells; Inflammatory bowel disease; Ubiquitination factor E4A

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN G; UBIQUITIN PROTEIN LIGASE; UBIQUITINATION FACTOR E4A; UBIQUITINATION FACTOR E4A ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA LIBRARY; ENTEROENDOCRINE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; ILEUM MUCOSA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; RANDOM SAMPLE; SCREENING TEST; ULCERATIVE COLITIS; UPREGULATION;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; BIOLOGICAL MARKERS; CROHN DISEASE; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; ILEUM; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; UBIQUITIN-PROTEIN LIGASES;

EID: 41149103489     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20328     Document Type: Article

References (40)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
2. Shanahan F. Crohn's disease. Lancet. 2002;359:62-69.
3. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
4. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
5. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495-549.
6. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol. 1997;148:567-576.
7. Shanahan F. The role of autoantibodies and autoimmunity in chronic inflammatory disorders of the gut. Curr Opin Gastroenterol. 1992;8: 988-992.
8. Wen Z, Fiocchi C. Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Clin Dev Immunol. 2004;11:195-204.
9. Regner M, Lambert PH. Autoimmunity through infection or immunization? Nat Immunol. 2001;2:185-188.
10. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, et al. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett. 2004;93:97-108.
11. Rankin GB, Watts HD, Melnyk CS, et al. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979;77:914-920.
12. Korsmeyer S, Strickland RG, Wilson ID, et al. Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease. Gastroenterology. 1974;67:578-583.
13. Mayet WJ, Press AG, Hermann E, et al. Antibodies to cytoskeletal proteins in patients with Crohn's disease. Eur J Clin Invest. 1990;20: 516-524.
14. Fricke H, Birkhofer A, Folwaczny C, et al. Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest. 1999; 29:41-45.
15. Shanahan F. Antibody markers in Crohn's disease: opportunity or overstatement? Gut. 1997;40:557-558.
16. Roche JK, Fiocchi C, Youngman K. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. Characterization of human intestinal mucosa-derived mononuclear cells reactive with purified epithelial cell-associated components in vitro. J Clin Invest. 1985;75:522-530.
17. Geng X, Biancone L, Dai HH, et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology. 1998;114:912-922.
18. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology. 1979;77:843-846.
19. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8-15.
20. Quinton JF, Sendid B, Reumaux D, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-791.
21. Ruemmele FM, Targan SR, Levy G, et al. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology. 1998;115:822-829.
22. Sutton CL, Kim J, Yamane A, et al. Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology. 2000;119: 23-31.
23. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689-699.
24. Targan SR, Landers CJ, Yang H, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology. 2005;128:2020-2028.
25. Seibold F, Weber P, Jenss H, et al. Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease. Gut. 1991;32: 1192-1197.
26. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem. 1998;67:425-479.
27. Weissman AM. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol. 2001;2:169-178.
28. Koegl M, Hoppe T, Schlenker S, et al. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell. 1999;96:635-644.
29. Hatakeyama S, Yada M, Matsumoto M, et al. U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem. 2001;276:33111-33120.
30. Hatakeyama S, Matsumoto M, Yada M, et al. Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones. Genes Cells. 2004;9:533-548.
31. Ohtsuka K, Hata M. Mammalian HSP40/DNAJ homologs: cloning of novel cDNAs and a proposal for their classification and nomenclature. Cell Stress Chaperones. 2000;5:98-112.
32. Scheufler C, Brinker A, Bourenkov G, et al. Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell. 2000;101:199-210.
33. Pellecchia M, Szyperski T, Wall D, et al. NMR structure of the J-domain and the Gly/Phe-rich region of the Escherichia coli DnaJ chaperone. J Mol Biol. 1996;260:236-250.
34. Contino G, Amati F, Pucci S, et al. Expression analysis of the gene encoding for the U-box-type ubiquitin ligase UBE4A in human tissues. Gene. 2004;328:69-74.
35. Skipper M, Lewis J. Getting to the guts of enteroendocrine differentiation. Nat Genet. 2000;24:3-4.
36. Bishop AE, Pietroletti R, Taat CW, et al. Increased populations of endocrine cells in Crohn's ileitis. Virchows Arch A Pathol Anat Histopathol. 1987;410:391-396.
37. O'Hara JR, Ho W, Linden DR, et al. Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis. Am J Physiol Gastrointest Liver Physiol. 2004;287:G998-1007.
38. Cohavy O, Harth G, Horwitz M, et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun. 1999;67:6510-6517.
39. Seibold F, Brandwein S, Simpson S, et al. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol. 1998;18:153-160.
40. Christen U, von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol. 2004;40:1113-1120.